홈 › 만성 폐쇄성 폐질환 › 사우스캐롤라이나
사우스캐롤라이나의 만성 폐쇄성 폐질환 임상 시험
만성 폐쇄성 폐질환 관련 연구 14개가 사우스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.
사우스캐롤라이나의 도시
공식 연구 텍스트(영어)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Anderson
- Research Site, Charleston
- Research Site, Gaffney
- 외 2개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- MedTrial- Site Number : 8400010, Columbia
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Clinical Research of Rock Hill, Rock Hill
피험자 모집 중2상
40세 ~ 85세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- AnMed Oglesby Center- Site Number : 8400074, Anderson
- MD First Research - Lancaster- Site Number : 8400102, Lancaster
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Lancaster
- Research Site, Spartanburg
피험자 모집 중2상
40세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Anderson
- Research Site, Columbia
- Research Site, Gaffney
- 외 2개
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Rock Hill
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Bogan Sleep Consultants, LLC, Columbia
- Velocity Clinical Research, Gaffney, Gaffney
- Clinical Research of Rock Hill, Rock Hill
- 외 1개
피험자 모집 중2/3상
35세 ~ 80세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
피험자 모집 중3상
18세 ~ 80세 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07555483STRIVE Post-Market Registry Study
- AnMed Health, Anderson
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Greenville
- GSK Investigational Site, Rock Hill
피험자 모집 중3상
40세 ~ 75세 · 모든 성별 · 2026. 7. 28. 업데이트됨 · NCT07177339Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Spartanburg
- GSK Investigational Site, Union
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06961214Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
- GSK Investigational Site, Rock Hill
피험자 모집 중3상
40세 ~ 80세 · 모든 성별 · 2025. 10. 8. 업데이트됨 · NCT06959095Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Medical University of South Carolina (MUSC), Charleston
- McLeod Health, Florence
피험자 모집 중관찰 연구
50세 이상 · 모든 성별 · 2025. 8. 5. 업데이트됨 · NCT06122077ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.